(Q45238248)

11 December 2017

title

Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy (English)

1 reference

11 December 2017

0 references

1

1 reference

11 December 2017

8

Ronald J A Wanders

1 reference

11 December 2017

Fredoen Valianpour

2

1 reference

11 December 2017

Simone Denis

3

1 reference

11 December 2017

Rob Ofman

4

1 reference

11 December 2017

Robert-Jan Sanders

5

1 reference

11 December 2017

Petra Mooyer

6

1 reference

11 December 2017

Peter G Barth

7

1 reference

11 December 2017

publication date

1 February 2005

1 reference

Molecular Genetics and Metabolism

11 December 2017

published in

1 reference

11 December 2017

volume

84

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

144-151

1 reference

Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Molecular Species of Phosphatidylcholine Containing Very Long Chain Fatty Acids in Human Brain: Enrichment in X-Linked Adrenoleukodystrophy Brain and Diseases of Peroxisome Biogenesis Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Role of very-long-chain acyl-coenzyme A synthetase in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

X-linked adrenoleukodystrophy: genes, mutations, and phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Fatty acid synthase, a proficient multifunctional enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Elongation of long-chain fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

The enzymic chain elongation of fatty acids by rat-liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Dietary erucic acid therapy for X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Successive isolation and separation of the major lipid fractions including gangliosides from single biological samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Increased Synthesis of Hexacosanoic Acid (C26 :0) by Cultured Skin Fibroblasts from Patients with Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN)1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

A mouse model for X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Cig30, a mouse member of a novel membrane protein gene family, is involved in the recruitment of brown adipose tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.09.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMGME.2004.09.015

1 reference

11 December 2017

1 reference